OR
Oliver Rolf Baumann bought $75K of VRXA stock
Oliver Rolf Baumann, Dir of Veraxa Biotech AG (VRXA), bought 50,000 shares of VRXA stock worth $75K, per an SEC Form 4 filed Aug 31, 2026.
It was an open-market purchase.
The trade happened on Aug 27, 2026, 4 days before it was made public.
VRXA has moved -28.5% since the trade date, from $1.44 to $1.03 (Nov 19, 2026 close).
- Traded
- Aug 27, 2026
- Disclosed
- Aug 31, 2026
- Filing delay
- 4 days
- Price since
- -28.5%
- Role
- Dir
- Source
- SEC Form 4